Identification of NleB2 mediated modifications in death domain proteins.

(A) Maxquant protein identification information for FADD in vitro glycosylation assays. For each sample the summed ion intensity, number of MS/MS events, score, sequence coverage, LFQ values and in vitro condition information are provided. (B) Maxquant peptide identification information for FADD in vitro glycosylation assays. For peptides identified within in vitro assays the peptide sequences, modification status, protein name, ion intensity, number of MS/MS events, score, data file of the best identification and in vitro condition information are provided. (C) Maxquant protein identification information for FasDD and TRAIL2 in vitro glycosylation assays. For each sample the summed ion intensity, number of MS/MS events, score, sequence coverage, LFQ values and in vitro condition information are provided. (D) Maxquant peptide identification information for FasDD and TRAIL2 in vitro glycosylation assays. For peptides identified within in vitro assays the peptide sequences, modification status, protein name, ion intensity, number of MS/MS events, score, data file of the best identification and in vitro condition information are provided. (E) Maxquant protein identification information for for pFlag-TNFR1DD / pFlag-TRADD and pGFP-NleB2 co-transfection assays. For each sample the summed ion intensity, number of MS/MS events, score, sequence coverage, LFQ values and co-transfection information are provided. (F) Maxquant peptide identification information for pFlag-TNFR1DD / pFlag-TRADD and pGFP-NleB2 co-transfection assays. For peptides identified within co-transfection assays the peptide sequences, modification status, protein name, ion intensity, number of MS/MS events, score, data file of the best identification and in vitro condition information are provided. (XLSX)